We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+9.14%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.16B
AUM Growth
+$3.85B
(+294%)
Cap. Flow
+$5.88B
Cap. Flow
% of AUM
113.91%
Top 10 Holdings %
Top 10 Hldgs %
56.91%
Holding
249
New
212
Increased
8
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$282M |
| 2 |
APC
Anadarko Petroleum
APC
|
+$281M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$261M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
+$219M |
| 5 |
AABA
Altaba Inc
AABA
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
S
Sprint Corporation
S
|
+$11.4M |
| 2 |
Pacific Biosciences
PACB
|
+$8.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.79% |
| 2 | Communication Services | 17.15% |
| 3 | Industrials | 13.68% |
| 4 | Healthcare | 8.58% |
| 5 | Real Estate | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Amphenol
APH
$210B
| $1.89M | 0.04% |
+78,856
| New | +$1.9M |
|
|
GBT
127
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.88M | 0.04% |
+35,800
| New | +$2.06M |
|
128
Heron Therapeutics
HRTX
$94.5M
| $1.86M | 0.04% |
+100,000
| New | +$2M |
|
129
Essex Property Trust
ESS
$18.3B
| $1.84M | 0.04% |
+6,300
| New | +$1.82M |
|
130
PUT
Transocean
RIG
$5.71B
| $1.73M | 0.03% |
+1,240,000
| New | +$9.21M |
|
|
PGTI
131
DELISTED
PGT, Inc.
PGTI
| $1.67M | 0.03% |
+100,000
| New | +$1.52M |
|
|
WW
132
PUT
DELISTED
WW International
WW
| $1.64M | 0.03% |
+295,000
| New | +$5.85M |
|
|
ACC
133
DELISTED
American Campus Communities, Inc.
ACC
| $1.59M | 0.03% |
+34,450
| New | +$1.62M |
|
|
DAY
134
DELISTED
Dayforce
DAY
| $1.54M | 0.03% |
+30,700
| New | +$1.55M |
|
135
NeoGenomics
NEO
$2B
| $1.51M | 0.03% |
+68,750
| New | +$1.51M |
|
136
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$818B
| $1.5M | 0.03% |
+5,500,000
| New | +$1.58B |
|
137
Qfin Holdings
QFIN
$1.59B
| $1.48M | 0.03% |
+126,050
| New | +$2.15M |
|
138
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $1.46M | 0.03% |
+5,000,000
| New | +$432M |
|
139
Q2 Holdings
QTWO
$3.95B
| $1.45M | 0.03% |
+19,000
| New | +$1.37M |
|
140
Impinj
PI
$5.25B
| $1.43M | 0.03% |
+50,000
| New | +$1.22M |
|
141
Fiverr
FVRR
$331M
| $1.35M | 0.03% |
+45,600
| New | +$1.4M |
|
142
PUT
Mattel
MAT
$4.21B
| $1.29M | 0.03% |
+1,017,500
| New | +$12M |
|
143
NNN REIT
NNN
$8.94B
| $1.29M | 0.03% |
+24,400
| New | +$1.3M |
|
|
LTC
144
LTC Properties
LTC
$2.02B
| $1.29M | 0.03% |
+28,200
| New | +$1.28M |
|
145
Warner Bros
WBD
$66.2B
| $1.29M | 0.03% |
+41,944
| New | +$1.22M |
|
146
Camden Property Trust
CPT
$11B
| $1.28M | 0.02% |
+12,300
| New | +$1.26M |
|
147
Corning
GLW
$135B
| $1.25M | 0.02% |
+37,500
| New | +$1.2M |
|
|
PPLI
148
People Inc
PPLI
$3.2B
| $1.16M | 0.02% |
+29,728
| New | +$1.19M |
|
|
FTR
149
PUT
DELISTED
Frontier Communications Corp.
FTR
| $1.1M | 0.02% |
+469,000
| New | +$956K |
|
150
Domo
DOMO
$179M
| $1.06M | 0.02% |
+38,974
| New | +$1.35M |
|
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q2 2019 Portfolio in Review
As of Q2 2019, UBS O'Connor held 249 positions worth $5.16B, up 294% from $1.31B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
UBS O'Connor deployed $5.88B of net new capital in Q2 2019, opening 212 new positions and adding to 8 existing holdings. Its largest new stake was Anadarko Petroleum: 4,191,507 shares worth $296M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Communication Services and Industrials.
On the sell side, the largest reduction was Pacific Biosciences, an estimated $8.98M trimmed.
- UBS O'Connor's largest Q2 2019 buy was Anadarko Petroleum: 4,191,507 shares worth $296M.
- UBS O'Connor added most to Worldpay, Inc. in Q2 2019, an estimated $282M increase.
- UBS O'Connor's biggest Q2 2019 reduction was Pacific Biosciences, cutting an estimated $8.98M.
- UBS O'Connor fully exited Sprint Corporation in Q2 2019, selling an estimated $11.4M.
- UBS O'Connor's ten largest holdings make up 57% of its $5.16B portfolio in Q2 2019.
- UBS O'Connor opened 212 new positions and closed 1 in Q2 2019.
- UBS O'Connor's portfolio value rose 294% quarter-over-quarter to $5.16B.
Based on UBS O'Connor's 13F filing for Q2 2019, filed 14 Aug 2019.